Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1969 1
1970 1
1971 1
1972 5
1973 3
1976 2
1977 4
1978 5
1979 1
1980 4
1981 3
1982 3
1983 2
1985 3
1987 2
1988 4
1989 3
1990 4
1991 1
1995 1
1996 1
1997 1
1998 5
1999 4
2000 8
2001 5
2002 4
2003 5
2004 1
2005 2
2006 6
2007 7
2008 8
2009 5
2010 6
2011 3
2012 9
2013 13
2014 10
2015 10
2016 15
2017 9
2018 21
2019 22
2020 18
2021 30
2022 40
2023 41
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: begaiym
Page 1
Showing results for begaiym mileva
Search for Begaiym Emileva instead (1 results)
Rose Flowers-A Delicate Perfume or a Natural Healer?
Mileva M, Ilieva Y, Jovtchev G, Gateva S, Zaharieva MM, Georgieva A, Dimitrova L, Dobreva A, Angelova T, Vilhelmova-Ilieva N, Valcheva V, Najdenski H. Mileva M, et al. Biomolecules. 2021 Jan 19;11(1):127. doi: 10.3390/biom11010127. Biomolecules. 2021. PMID: 33478154 Free PMC article. Review.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.
Mileva N, Nagumo S, Mizukami T, Sonck J, Berry C, Gallinoro E, Monizzi G, Candreva A, Munhoz D, Vassilev D, Penicka M, Barbato E, De Bruyne B, Collet C. Mileva N, et al. J Am Heart Assoc. 2022 Apr 5;11(7):e023207. doi: 10.1161/JAHA.121.023207. Epub 2022 Mar 18. J Am Heart Assoc. 2022. PMID: 35301851 Free PMC article. Review.
The Mileva Story.
Kravitz ND. Kravitz ND. J Clin Orthod. 2023 Aug;57(8):435. J Clin Orthod. 2023. PMID: 37778116 No abstract available.
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Pizzi C, Barbato E. Paolisso P, et al. Pharmacol Res. 2023 Jan;187:106597. doi: 10.1016/j.phrs.2022.106597. Epub 2022 Dec 5. Pharmacol Res. 2023. PMID: 36470546 Free PMC article.
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.
Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Cardiovasc Diabetol. 2022 May 15;21(1):77. doi: 10.1186/s12933-022-01506-8. Cardiovasc Diabetol. 2022. PMID: 35570280 Free PMC article.
Impact of Different Mechanical and Metabolic Stimuli on the Temporal Dynamics of Muscle Strength Adaptation.
Lambrianides Y, Epro G, Smith K, Mileva KN, James D, Karamanidis K. Lambrianides Y, et al. J Strength Cond Res. 2022 Nov 1;36(11):3246-3255. doi: 10.1519/JSC.0000000000004300. Epub 2022 Jul 1. J Strength Cond Res. 2022. PMID: 36287182 Review.
Lambrianides, Y, Epro, G, Smith, K, Mileva, K, James, D, and Karamanidis, K. Impact of different mechanical and metabolic stimuli on the temporal dynamics of muscle strength adaptation. ...
Lambrianides, Y, Epro, G, Smith, K, Mileva, K, James, D, and Karamanidis, K. Impact of different mechanical and metabolic stimuli on …
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
335 results